422P the Efficacy and Safety of Irinotecan Plus Raltitrexed As Second-Line Treatment in Advanced Colorectal Cancer (ACC) Patients: A Summary Analysis of a Multicenter, Phase II Trial
Annals of Oncology(2021)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined